Bixiye
Interleukin (IL) -1 Inhibitors - Medicaid
Prior Authorization, Quantity Limit
Taariikhda uu dhaqangalayo barnaamijka: Okt 01, 2025
Dukumentiyadda & Foomamka Natiijooyinka
Soo bandhiga 1471 - 1480 ee natiijooyinka 3613
Bixiye
Interleukin (IL) -1 Inhibitors - Commercial
Prior Authorization, Quantity Limit
Taariikhda uu dhaqangalayo barnaamijka: Okt 01, 2025
Bixiye
QP86-21 Commercial Pharmacy Benefit Exclusion for Mitigare®
Taariikhda uu dhaqangalayo Barnaamijka: Nov 10, 2021
Bixiye
QP87-21 Commercial Pharmacy Benefit Update – New and Revised Drug-Related Prior Authorization (PA) Requirement Notification – Effective January 1, 2022
Taariikhda uu dhaqangalayo Barnaamijka: Nov 10, 2021
Bixiye
QP88-21 MHCP Pharmacy Benefit Exclusion for Tivdak
Taariikhda uu dhaqangalayo Barnaamijka: Nov 10, 2021
Bixiye
QP89-21 Pharmacy Benefit Exclusion for Lantus and Lantus Solostar
Taariikhda uu dhaqangalayo Barnaamijka: Nov 10, 2021
Bixiye
QP90-21 Update for New to Market Medical Drugs: Tezepelumab, Faricimab, and Ranibizumab Injection (Susvimo implant)
Taariikhda uu dhaqangalayo Barnaamijka: Nov 10, 2021
Bixiye
QP91-21 Propeller – A Digital Health Resource for Select Blue Cross and Blue Shield of Minnesota Health Plan Members
Taariikhda uu dhaqangalayo Barnaamijka: Nov 10, 2021
Bixiye
QP92-21 Federal Employee Program Plans Migration of Dental Coverage to United Concordia Dental
Taariikhda uu dhaqangalayo Barnaamijka: Nov 24, 2021
Bixiye
QP93-21Electronic Data Interchange Process for Availity Transactions for Minnesota Health Care Programs
Taariikhda uu dhaqangalayo Barnaamijka: Nov 24, 2021